Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Menis · SciRah

Researcher profile · Semantic Scholar

J. Menis

Share profile

J. Menis — researcher profile on SciRah

h-index: 26
Works: 116
Citations: 3,281

Most-cited papers

Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
L. Hendriks, K. Kerr, J. Menis, T. Mok +8 more
2023Annals of Oncology805 citations Open access
Semantic Scholar
Non-oncogene addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†.
L. Hendriks, K. Kerr, J. Menis, T. Mok +8 more
2023Annals of Oncology574 citations Open access
Semantic Scholar
Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score).
F. Bigot, E. Castañón, C. Baldini, A. Hollebecque +14 more
2017European Journal of Cancer217 citations Open access
Semantic Scholar
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer.
G. Pasello, A. Pavan, I. Attili, A. Bortolami +4 more
2020Cancer Treatment Reviews128 citations Open access
Semantic Scholar
METEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours
L. Siu, D. Rasco, S. P. Vinay, P. Romano +9 more
2019Annals of Oncology106 citations Open access
Semantic Scholar
The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613.
J. Remon, J. Menis, B. Hasan, A. Peric +7 more
2017Clinical Lung Cancer92 citations Open access
Semantic Scholar
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
J. Menis, B. Hasan, B. Besse
2014European Respiratory Review90 citations Open access
Semantic Scholar
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy.
L. Evangelista, Lea Cuppari, J. Menis, L. Bonanno +3 more
2019Nuclear medicine communications66 citations
Semantic Scholar
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis
F. Passiglia, M. Cinquini, L. Bertolaccini, M. Del Re +12 more
2021Journal of Clinical Oncology62 citations Open access
Semantic Scholar
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations.
M. Riudavets, E. Auclin, M. Mosteiro, N. Dempsey +34 more
2022European Journal of Cancer55 citations Open access
Semantic Scholar
Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection.
G. Banna, F. Passiglia, F. Colonese, S. Canova +4 more
2018Critical reviews in oncology/hematology48 citations
Semantic Scholar
Outcomes of First‐Generation EGFR‐TKIs Against Non‐Small‐Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE‐POSITIVE Study
S. Pilotto, A. Rossi, T. Vavalà, A. Follador +25 more
2018Clinical Lung Cancer46 citations Open access
Semantic Scholar
A randomised open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC - the ETOP and EORTC SPLENDOUR trial.
S. Peters, S. Danson, B. Hasan, U. Dafni +34 more
2020Journal of Thoracic Oncology40 citations Open access
Semantic Scholar
Long-term update of the 24954 EORTC phase III trial on larynx preservation.
B. de Figueiredo, C. Fortpied, J. Menis, J. Lefebvre +11 more
2016European Journal of Cancer40 citations Open access
Semantic Scholar
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)
J. Machiels, P. Bossi, J. Menis, M. Lia +19 more
2018Annals of Oncology39 citations Open access
Semantic Scholar
Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio
Alberto Bongiovanni, F. Foca, J. Menis, S. Stucci +11 more
2021Frontiers in Immunology38 citations Open access
Semantic Scholar
SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs
L. Belluomini, L. Calvetti, A. Inno, G. Pasello +5 more
2022Frontiers in Oncology37 citations Open access
Semantic Scholar
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?
L. Belluomini, A. Caldart, A. Avancini, A. Dodi +10 more
2020International Journal of Molecular Sciences37 citations Open access
Semantic Scholar
The European Organization for Research and Treatment of Cancer perspective on designing clinical trials with immune therapeutics.
J. Menis, S. Litière, K. Tryfonidis, V. Golfinopoulos
2016Annals of Translational Medicine35 citations Open access
Semantic Scholar
Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064).
M. O'Brien, R. Gaafar, B. Hasan, J. Menis +10 more
2015European Journal of Cancer34 citations Open access
Semantic Scholar
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.
F. Passiglia, L. Bertolaccini, M. Del Re, F. Facchinetti +10 more
2020Critical reviews in oncology/hematology31 citations
Semantic Scholar
Exploring the Role of Respiratory Microbiome in Lung Cancer: a Systematic Review.
F. Perrone, L. Belluomini, M. Mazzotta, M. Bianconi +15 more
2021Critical reviews in oncology/hematology29 citations
Semantic Scholar
A multimodal approach to cancer-related cachexia: from theory to practice
A. Avancini, I. Trestini, D. Tregnago, M. Lanza +4 more
2021Expert Review of Anticancer Therapy28 citations
Semantic Scholar
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial
S. Peters, S. Danson, B. Hasan, U. Dafni +34 more
202028 citations Open access
Semantic Scholar
Perioperative treatment strategies in EGFR-mutant early-stage NSCLC: current evidence and future challenges.
J. Remon, S. P. Saw, F. Cortiula, P. K. Singh +3 more
2023Journal of Thoracic Oncology26 citations Open access
Semantic Scholar
LBA85 REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer
B. Besse, J. Menis, P. Bironzo, R. Gervais +16 more
202024 citations Open access
Semantic Scholar
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061).
F. Abdelraouf, E. Smit, B. Hasan, J. Menis +5 more
2016European Journal of Cancer24 citations
Semantic Scholar
Prospects of targeted and immune therapies in SCLC
L. Hendriks, J. Menis, M. Reck
2018Expert Review of Anticancer Therapy22 citations Open access
Semantic Scholar
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done
L. Belluomini, A. Dodi, A. Caldart, D. Kadrija +9 more
2021Translational Lung Cancer Research20 citations Open access
Semantic Scholar
MET inhibition in lung cancer.
J. Menis, M. G. Levra, S. Novello
2013Translational Lung Cancer Research20 citations
Semantic Scholar
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey.
S. Pilotto, A. Avancini, J. Menis, I. Sperduti +21 more
2022Lung Cancer19 citations Open access
Semantic Scholar
How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review
J. Remon, J. Menis, A. Lévy, D. D. De Ruysscher +1 more
2021Translational Lung Cancer Research19 citations Open access
Semantic Scholar
Immunotherapy in malignant pleural mesothelioma: a review of literature data
J. Menis, G. Pasello, J. Remon
2021Translational Lung Cancer Research19 citations Open access
Semantic Scholar
TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial
P. Specenier, É. Remenár, Jan Buter, Dirk Schrijvers +7 more
2017Annals of Oncology18 citations Open access
Semantic Scholar
Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer
Alice Boscolo, F. Fortarezza, F. Lunardi, G. Comacchio +9 more
2020Frontiers in Oncology15 citations Open access
Semantic Scholar
Combination of Immunotherapy and Radiotherapy-The Next Magic Step in the Management of Lung Cancer?
L. Hendriks, J. Menis, D. D. De Ruysscher, M. Reck
2020Journal of Thoracic Oncology15 citations Open access
Semantic Scholar
EORTC-ETOP randomized, phase 3 trial with anti-PD-1 monoclonal antibody pembrolizumab versus placebo for patients with early stage non-small cell lung cancer (NSCLC) after resection and standard adjuvant chemotherapy: PEARLS (NCT02504372).
M. O'Brien, B. Hasan, U. Dafni, J. Menis +10 more
201615 citations
Semantic Scholar
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.
T. Vavalà, A. Follador, M. Tiseo, D. Galetta +24 more
2016Lung Cancer15 citations Open access
Semantic Scholar
HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series
G. Aprile, Giovanna De Maglio, J. Menis, M. Casagrande +7 more
2013International Journal of Molecular Sciences15 citations Open access
Semantic Scholar
Brain metastases from gastrointestinal tumours: tailoring the approach to maximize the outcome.
J. Menis, C. Fontanella, A. Follador, G. Fasola +1 more
2013Critical reviews in oncology/hematology15 citations
Semantic Scholar
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?
S. Watson, J. Menis, C. Baldini, P. Martin-Romano +7 more
2018British Journal of Cancer14 citations Open access
Semantic Scholar
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study
M. Sposito, L. Belluomini, Riccardo Nocini, J. Insolda +25 more
2024Frontiers in Oncology13 citations Open access
Semantic Scholar
Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis
E. Gobbini, L. Bertolaccini, N. Giaj-Levra, J. Menis +1 more
2021Translational Lung Cancer Research12 citations Open access
Semantic Scholar
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center
G. Pasello, J. Menis, S. Pilotto, S. Frega +18 more
2021Frontiers in Oncology12 citations Open access
Semantic Scholar
Dacomitinib for the first-line treatment of patients with EGFR-mutated metastatic non-small cell lung cancer
M. Santarpia, J. Menis, I. Chaib, María González Cao +1 more
2019Expert Review of Clinical Pharmacology12 citations
Semantic Scholar
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines.
A. Dal Maso, M. Lorenzi, A. Ferro, S. Pilotto +16 more
2021Future Oncology11 citations Open access
Semantic Scholar
Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectives
G. Sartori, L. Belluomini, F. Lombardo, A. Avancini +7 more
2020Expert Review of Anticancer Therapy11 citations
Semantic Scholar
71TiPA randomized, phase 3 trial with anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) versus placebo for patients with early stage NSCLC after resection and completion of standard adjuvant therapy (EORTC/ETOP 1416-PEARLS)
L. Paz-Ares, B. Hasan, U. Dafni, J. Menis +6 more
201711 citations Open access
Semantic Scholar
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study
A. Psyrri, C. Fortpied, G. Koutsodontis, M. Avgeris +15 more
2017Annals of Oncology9 citations Open access
Semantic Scholar
Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer
K. Tryfonidis, C. Papadaki, S. Assele, E. Lagoudaki +9 more
2019The Pharmacogenomics Journal8 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Pilotto×12
Invite
S. Pilotto — researcher profile on SciRah
B. Hasan×10
Invite
B. Hasan — researcher profile on SciRah
S. Novello×8
Invite
S. Novello — researcher profile on SciRah
B. Besse×8
Invite
B. Besse — researcher profile on SciRah

×8

Invite

L. Belluomini — researcher profile on SciRah

Invite

M. Milella — researcher profile on SciRah

Invite

M. Reck — researcher profile on SciRah

Invite

L. Bonanno — researcher profile on SciRah

Invite

J. Remon — researcher profile on SciRah

Invite

E. Bria — researcher profile on SciRah

Invite

M. O'Brien — researcher profile on SciRah

Invite

A. Avancini — researcher profile on SciRah